Cross-source evidence timeline

Calcitonin salmon research timeline

Follow 57 selected, directly cited source records from April 17, 1978 through October 29, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.

57Selected records
20Source years
3Evidence lanes
October 29, 2026Latest source date

Source year

2026

3 records
  1. Regulatory

    Drugs@FDA application ANDA216996↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 216996 with status AP dated 2026-10-29, and names calcitonin salmon among the application record's active ingredients.↗

  2. Literature metadata

    Salmon calcitonin prescribing for acute phantom limb pain after amputation.↗

    PubMed lists PMID 42919113 in Anaesthesia as Journal Article, with publication-date metadata of 2026-10-22 (day precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Regulatory

    Drugs@FDA application ANDA215864↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 215864 with status AP dated 2026-03-04, and names calcitonin salmon among the application record's active ingredients.↗

Source year

2025

3 records
  1. Regulatory

    Drugs@FDA application ANDA216294↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 216294 with status AP dated 2025-09-26, and names calcitonin salmon among the application record's active ingredients.↗

  2. Regulatory

    Drugs@FDA application ANDA219196↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 219196 with status AP dated 2025-07-09, and names calcitonin salmon among the application record's active ingredients.↗

  3. Literature metadata

    Production of biologically active recombinant salmon calcitonin in Escherichia coli and fish cell line.↗

    PubMed lists PMID 39862273 in Archives of microbiology as Journal Article, with publication-date metadata of 2025-01-25 (day precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2024

6 records
  1. Regulatory

    Drugs@FDA application ANDA212675↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 212675 with status AP dated 2024-12-05, and names calcitonin salmon among the application record's active ingredients.↗

  2. Regulatory

    Drugs@FDA application ANDA213766↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 213766 with status AP dated 2024-09-20, and names calcitonin salmon among the application record's active ingredients.↗

  3. Clinical trials

    ClinicalTrials.gov record NCT03935984↗

    PeptideScanner retained ClinicalTrials.gov record NCT03935984 at 2026-11-15T21:54:02.201Z. Its registry update date was 2024-09-19, and PeptideScanner's reviewed identity mapping was calcitonin-salmon.↗

  4. Clinical trials

    ClinicalTrials.gov record NCT03812991↗

    PeptideScanner retained ClinicalTrials.gov record NCT03812991 at 2026-11-15T21:54:02.201Z. Its registry update date was 2024-06-11, and PeptideScanner's reviewed identity mapping was calcitonin-salmon.↗

  5. Literature metadata

    Tuning the double lipidation of salmon calcitonin to introduce a pore-like membrane translocation mechanism.↗

    PubMed lists PMID 38713958 in Journal of colloid and interface science as Journal Article, with publication-date metadata of 2024-04-15 (day precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  6. Regulatory

    Drugs@FDA application ANDA215715↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 215715 with status AP dated 2024-04-11, and names calcitonin salmon among the application record's active ingredients.↗

Source year

2023

1 record
  1. Regulatory

    Federal Register notice 2023-03389↗

    The Federal Register published notice 2023-03389, attributed to FDA and its parent HHS department, on 2023-02-17. Its official title is “Determination That MIACALCIN (Calcitonin Salmon) Injection, 100 USP Units/Milliliter (mL), Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Calcitonin salmon.↗

Source year

2022

4 records
  1. Regulatory

    Federal Register notice 2022-25210↗

    The Federal Register published notice 2022-25210, attributed to FDA and its parent HHS department, on 2022-11-18. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Calcitonin salmon and Goserelin.↗

  2. Literature metadata

    Calcitonin (FORTICAL, MIACALCIN) for the treatment of vertebral compression fractures.↗

    PubMed lists PMID 34745472 in Orthopedic reviews as Journal Article, with publication-date metadata of 2021-06-21 (day precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Literature metadata

    Preparation and characterization of an electrospun colon-specific delivery system for salmon calcitonin.↗

    PubMed lists PMID 35540827 in RSC advances as Journal Article, with publication-date metadata of 2018-03-08 (day precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  4. Clinical trials

    ClinicalTrials.gov record NCT03342001↗

    PeptideScanner retained ClinicalTrials.gov record NCT03342001 at 2026-11-15T21:54:02.201Z. Its registry update date was 2022-02-21, and PeptideScanner's reviewed identity mapping was calcitonin-salmon.↗

Source year

2021

7 records
  1. Regulatory

    Drugs@FDA application ANDA209358↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 209358 with status AP dated 2021-11-10, and names calcitonin salmon among the application record's active ingredients.↗

  2. Literature metadata

    Salmon calcitonin: a review of current and future therapeutic indications.↗

    PubMed lists PMID 18071651 in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA as Journal Article, Review, with publication-date metadata of 2007-12-11 (day precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Regulatory

    Drugs@FDA application ANDA212416↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 212416 with status AP dated 2021-05-14, and names calcitonin salmon among the application record's active ingredients.↗

  4. Literature metadata

    Salmon calcitonin distributes into the arcuate nucleus to a subset of NPY neurons in mice.↗

    PubMed lists PMID 32035146 in Neuropharmacology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2020-02-05 (day precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  5. Literature metadata

    Impurities identification and quantification for calcitonin salmon by liquid chromatography-high resolution mass spectrometry.↗

    PubMed lists PMID 32247161 in Journal of pharmaceutical and biomedical analysis as Journal Article, with publication-date metadata of 2020-03-20 (day precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  6. Literature metadata

    Thermosensitive Hydrogel Based on Poly(2-Ethyl-2-Oxazoline)-Poly(D,L-Lactide)-Poly(2-Ethyl-2-Oxazoline) for Sustained Salmon Calcitonin Delivery.↗

    PubMed lists PMID 31953574 in AAPS PharmSciTech as Journal Article, with publication-date metadata of 2020-01-17 (day precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  7. Literature metadata

    Type II Turn of Receptor-bound Salmon Calcitonin Revealed by X-ray Crystallography.↗

    PubMed lists PMID 27189946 in The Journal of biological chemistry as Journal Article, with publication-date metadata of 2016-05-04 (day precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2020

4 records
  1. Regulatory

    Federal Register notice 2020-23300↗

    The Federal Register published notice 2020-23300, attributed to FDA and its parent HHS department, on 2020-10-21. Its official title is “Determination That BUTISOL SODIUM (Butabarbital Sodium) Oral Tablets, 15 Milligrams, 50 Milligrams, and 100 Milligrams, and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Calcitonin salmon.↗

  2. Literature metadata

    Monosialoganglioside-GM1 triggers binding of the amyloid-protein salmon calcitonin to a Langmuir membrane model mimicking the occurrence of lipid-rafts.↗

    PubMed lists PMID 28955978 in Biochemistry and biophysics reports as Journal Article, with publication-date metadata of 2016-10-15 (day precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Literature metadata

    The Interaction between Amyloid Prefibrillar Oligomers of Salmon Calcitonin and a Lipid-Raft Model: Molecular Mechanisms Leading to Membrane Damage, Ca2+-Influx and Neurotoxicity.↗

    PubMed lists PMID 31905804 in Biomolecules as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-12-29 (day precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  4. Literature metadata

    Ultrasound parameters in osteoporotic patients treated with salmon calcitonin: a longitudinal study.↗

    PubMed lists PMID 8883119 in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1996 (year precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2019

8 records
  1. Literature metadata

    Densitometric analysis in in vivo evaluation of synthetic salmon calcitonin activity.↗

    PubMed lists PMID 3392126 in Journal of clinical pharmacy and therapeutics as Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1988-04 (month precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Regulatory

    Federal Register notice 2019-19347↗

    The Federal Register published notice 2019-19347, attributed to FDA and its parent HHS department, on 2019-09-09. Its official title is “Determination That CALCIMAR (calcitonin salmon) Injection, 200 International Units Per Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Calcitonin salmon.↗

  3. Literature metadata

    Intrapulmonary drug delivery of salmon calcitonin.↗

    PubMed lists PMID 9312206 in Calcified tissue international as Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1997-10 (month precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  4. Literature metadata

    Total and regional bone mineral content and fracture rate in postmenopausal osteoporosis treated with salmon calcitonin: a prospective study.↗

    PubMed lists PMID 7750020 in Calcified tissue international as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1995-03 (month precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  5. Literature metadata

    Salmon calcitonin in the acute management of hypercalcemia.↗

    PubMed lists PMID 2137363 in Calcified tissue international as Comparative Study, Journal Article, Review, with publication-date metadata of 1990 (year precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  6. Literature metadata

    Deterioration of renal bone disease in patients treated with salmon calcitonin.↗

    PubMed lists PMID 7042129 in Clinical endocrinology as Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1982-01 (month precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  7. Literature metadata

    Salmon calcitonin in the treatment of postmenopausal osteoporosis.↗

    PubMed lists PMID 3318613 in Annals of internal medicine as Journal Article, Review, with publication-date metadata of 1987-12 (month precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  8. Literature metadata

    Experts recommend against calcitonin-salmon for postmenopausal osteoporosis.↗

    PubMed lists PMID 23552038 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as News, with publication-date metadata of 2013-04-15 (day precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2018

4 records
  1. Literature metadata

    Intra-articular delivery of a nanocomplex comprising salmon calcitonin, hyaluronic acid, and chitosan using an equine model of joint inflammation.↗

    PubMed lists PMID 29947020 in Drug delivery and translational research as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2018-10 (month precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    Design of chondroitin sulfate-based polyelectrolyte nanoplexes: Formation of nanocarriers with chitosan and a case study of salmon calcitonin.↗

    PubMed lists PMID 27842824 in Carbohydrate polymers as Journal Article, with publication-date metadata of 2016-09-13 (day precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Regulatory

    Federal Register notice 2018-25187↗

    The Federal Register published notice 2018-25187, attributed to FDA and its parent HHS department, on 2018-11-19. Its official title is “Determination That REGITINE (Phentolamine Mesylate) Injection, 5 Milligrams/Vial, and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Calcitonin salmon.↗

  4. Literature metadata

    Does salmon calcitonin cause cancer? A review and meta-analysis.↗

    PubMed lists PMID 26438308 in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA as Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2015-10-05 (day precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2017

2 records
  1. Clinical trials

    ClinicalTrials.gov record NCT01652573↗

    PeptideScanner retained ClinicalTrials.gov record NCT01652573 at 2026-11-15T21:54:02.201Z. Its registry update date was 2017-05-31, and PeptideScanner's reviewed identity mapping was calcitonin-salmon.↗

  2. Literature metadata

    [The influence of salmon calcitonin on the soluble form of VCAM-1 (CD 106) and E-selectin (CD 62E) in serum of patients with atopic bronchial asthma].↗

    PubMed lists PMID 9640081 in Polskie Archiwum Medycyny Wewnetrznej as Clinical Trial, Controlled Clinical Trial, English Abstract, Journal Article, with publication-date metadata of 1997-12 (month precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2016

5 records
  1. Literature metadata

    Salmon calcitonin in the treatment of elderly women with type 2 diabetes complicated with osteoporosis.↗

    PubMed lists PMID 25410076 in Pakistan journal of pharmaceutical sciences as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2014-11 (month precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    [Salmon calcitonin in the treatment of osteoporosis].↗

    PubMed lists PMID 11045148 in Vnitrni lekarstvi as Clinical Trial, Journal Article, with publication-date metadata of 1999-08 (month precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Literature metadata

    [Treatment of primary osteoporosis with calcium and salmon calcitonin].↗

    PubMed lists PMID 2199180 in Deutsche medizinische Wochenschrift (1946) as Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1990-08-03 (day precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  4. Literature metadata

    Salmon calcitonin in the treatment of bone metastases.↗

    PubMed lists PMID 3721646 in International journal of clinical pharmacology research as Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, with publication-date metadata of 1986 (year precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  5. Literature metadata

    [Synthetic salmon calcitonin suppositories for the short-term treatment of involutive osteoporosis].↗

    PubMed lists PMID 7603605 in Minerva medica as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1995-03 (month precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2013

1 record
  1. Regulatory

    Federal Register notice 2013-00507↗

    The Federal Register published notice 2013-00507, attributed to FDA and its parent HHS department, on 2013-01-14. Its official title is “Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Calcitonin salmon.↗

Source year

2012

1 record
  1. Regulatory

    Federal Register notice 2012-22658↗

    The Federal Register published notice 2012-22658, attributed to FDA and its parent HHS department, on 2012-09-14. Its official title is “Draft and Revised Draft Guidances for Industry Describing Product-Specific Bioequivalence Recommendations; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Calcitonin salmon.↗

Source year

2009

1 record
  1. Regulatory

    Drugs@FDA application ANDA076979↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 076979 with status AP dated 2009-06-08, and names calcitonin salmon among the application record's active ingredients.↗

Source year

2008

1 record
  1. Regulatory

    Drugs@FDA application ANDA076396↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 076396 with status AP dated 2008-11-17, and names calcitonin salmon among the application record's active ingredients.↗

Source year

2007

2 records
  1. Literature metadata

    [Salmon calcitonin in metastatic bone pain. Demonstration of acute analgesia in tumor patients].↗

    PubMed lists PMID 6376042 in Deutsche medizinische Wochenschrift (1946) as Clinical Trial, English Abstract, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1984-06-15 (day precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Regulatory

    Federal Register notice E7-21886↗

    The Federal Register published notice E7-21886, attributed to FDA and its parent HHS department, on 2007-11-07. Its official title is “Lederle Laboratories et al.; Withdrawal of Approval of 73 New Drug Applications and 62 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Calcitonin salmon.↗

Source year

2005

1 record
  1. Regulatory

    Drugs@FDA application NDA021406↗

    The official Drugs@FDA dataset lists original submission 1 for NDA 021406 with status AP dated 2005-08-12, and names calcitonin salmon recombinant among the application record's active ingredients.↗

Source year

1995

1 record
  1. Regulatory

    Drugs@FDA application NDA020313↗

    The official Drugs@FDA dataset lists original submission 1 for NDA 020313 with status AP dated 1995-08-17, and names calcitonin salmon among the application record's active ingredients.↗

Source year

1986

1 record
  1. Regulatory

    Drugs@FDA application NDA017808↗

    The official Drugs@FDA dataset lists original submission 1 for NDA 017808 with status AP dated 1986-07-03, and names calcitonin salmon among the application record's active ingredients.↗

Source year

1978

1 record
  1. Regulatory

    Drugs@FDA application NDA017769↗

    The official Drugs@FDA dataset lists original submission 1 for NDA 017769 with status AP dated 1978-04-17, and names calcitonin salmon among the application record's active ingredients.↗